Concepedia

Subodh Kumar

SK

Statistics

Publications

13

Citations

618

H-Index

12

Active since

2007

Affiliations

Dana-Farber Cancer Institute(Current)

VA Boston Healthcare System

Harvard University

Dana-Farber/Harvard Cancer Center

Pt. Jawahar Lal Nehru Memorial Medical College

Subodh Kumar is an author at Dana-Farber Cancer Institute specializing in molecular oncology, oncology, and life sciences.

Publications per year

2007–2023

13

Publications

13

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

Lei Wang, Jianjun Chang, Diana Varghese et al. · Nature Communications · 2013 · 324 citations · Full text

Medicine, Cancer Biology, Oncology +12

Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance

Subodh Kumar, Srikanth Talluri, Jagannath Pal et al. · Blood Cancer Journal · 2018 · 53 citations · Full text

Medicine, Molecular Biology, Oncology +16

Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma

Srikanth Talluri, Mehmet Samur, Leutz Buon et al. · Blood Cancer Journal · 2021 · 47 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia

Na Li, Michael Lopez, María Linares et al. · Clinical Cancer Research · 2018 · 34 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Agonist-mediated docking of androgen receptor onto the mitotic chromatin platform discriminates intrinsic mode of action of prostate cancer drugs

Sanjay Kumar, Nagendra K. Chaturvedi, Subodh Kumar et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2007 · 31 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

1–5 of 13